Dogwood Therapeutics, Inc. Shares Outstanding (Cover Page)
Dogwood Therapeutics, Inc. (DWTX) had Shares Outstanding (Cover Page) of 33.99 million shares as of 2026-08-13, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-13: Entity Common Stock, Shares Outstanding 33.99M shares.
- 2026-05-13: Entity Common Stock, Shares Outstanding 33.63M shares.
- 2026-03-10: Entity Common Stock, Shares Outstanding 33.40M shares.
- 2025-11-05: Entity Common Stock, Shares Outstanding 2.29M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-13 | 33.99M shares 10-Q · filed 2026-08-14 |
| 2026-05-13 | 33.63M shares 10-Q · filed 2026-05-15 |
| 2026-03-10 | 33.40M shares 10-K · filed 2026-03-18 |
| 2025-11-05 | 2.29M shares 10-Q · filed 2025-11-07 |
| 2025-08-06 | 1.91M shares 10-Q · filed 2025-08-13 |
| 2025-05-06 | 1.91M shares 10-Q · filed 2025-05-09 |
| 2025-03-27 | 1.91M shares 10-K · filed 2025-03-31 |
| 2024-11-06 | 1.33M shares 10-Q · filed 2024-11-08 |
| 2024-08-07 | 27.76M shares 10-Q · filed 2024-08-09 |
| 2024-05-08 | 19.26M shares 10-Q · filed 2024-05-10 |
| 2024-02-26 | 19.26M shares 10-K/A · filed 2024-03-08 |
| 2023-11-09 | 19.26M shares 10-Q · filed 2023-11-13 |
| 2023-08-09 | 19.25M shares 10-Q · filed 2023-08-11 |
| 2023-05-10 | 18.33M shares 10-Q · filed 2023-05-12 |
| 2023-03-10 | 18.33M shares 10-K · filed 2023-03-14 |
| 2022-11-11 | 18.33M shares 10-Q · filed 2022-11-14 |
| 2022-08-11 | 8.33M shares 10-Q · filed 2022-08-12 |
| 2022-05-12 | 8.33M shares 10-Q · filed 2022-05-13 |
| 2022-03-15 | 8.33M shares 10-K · filed 2022-03-18 |
| 2021-11-11 | 8.33M shares 10-Q · filed 2021-11-12 |
| 2021-08-12 | 8.33M shares 10-Q · filed 2021-08-13 |
| 2021-05-12 | 8.33M shares 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |